Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis

Multiple Sclerosis

Volumn 22, Issue 4, 2016, Pages 470-482

  Ramanathan, Sudarshini ^a   Prelog, Kristina ^b   Barnes, Elizabeth H ^c   Tantsis, Esther M ^a   Reddel, Stephen W ^c,d   Henderson, Andrew P D ^a,e   Vucic, Steve ^a,c   Gorman, Mark P ^f   Benson, Leslie A ^f   Alper, Gulay ^g   Riney, Catherine J ^h   Barnett, Michael ^c,i   Parratt, John D E ^c   Hardy, Todd A ^c,d   Leventer, Richard J ^j   Merheb, Vera ^a   Nosadini, Margherita ^a   Fung, Victor S C ^a   Brilot, Fabienne ^a   Dale, Russell C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Department of Microbiology and Infectious Diseases   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^h LADY CILENTO CHILDREN S HOSPITAL   (Australia)

ⁱ ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

aquaporin 4 antibodies; multiple sclerosis; myelin oligodendrocyte glycoprotein antibodies; neuromyelitis optica; Optic neuritis; radiology

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; BIOLOGICAL MARKER; MOG PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CHILD; CONTROLLED STUDY; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC NERVE DISEASE; OPTIC NEURITIS; OPTIC TRACT; RETROBULBAR OPTIC NEUROPATHY; RETROSPECTIVE STUDY; SCORING SYSTEM; VISUAL IMPAIRMENT; BLOOD; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; IMMUNOLOGY; MIDDLE AGED; ONSET AGE; PREDICTIVE VALUE; PRESCHOOL CHILD; YOUNG ADULT; CONTRAST ENHANCEMENT; FLOW CYTOMETRY; FUNCTIONAL NEUROIMAGING; IMMUNOFLUORESCENCE; MYELITIS; OPTIC NERVE; PLASMAPHERESIS; VISUAL ACUITY;

ADOLESCENT; ADULT; AGE OF ONSET; AQUAPORIN 4; AUTOANTIBODIES; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OPTIC NEURITIS; OPTIC TRACT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84962571652     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515593406     Document Type: Article

References (31)

1. Compston A, Coles A,. Multiple sclerosis. Lancet 2008; 372: 1502-1517.
2. Toosy AT, Mason DF, Miller DH,. Optic neuritis. Lancet Neurol 2014; 13: 83-99.
3. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
4. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
5. Brilot F, Dale RC, Selter RC, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 2009; 66: 833-842.
6. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 2011; 8: 184.
7. Rostasy K, Mader S, Schanda K, et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 2012; 69: 752-756.
8. Rostasy K, Mader S, Hennes EM, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 2013; 19: 1052-1059.
9. Dale RC, Tantsis E, Merheb V, et al. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Neurol Neuroimmunol Neuroinflamm 2014; 1: e12.
10. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012; 79: 1273-1277.
11. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: A comparative study. JAMA Neurol 2014; 71: 276-283.
12. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474-481.
13. Ramanathan S, Reddel SW, Henderson A, et al. Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 2014; 1: e40.
14. Hoftberger R, Sepulveda M, Armangue T, et al. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 2015; 21: 866-874.
15. Sakuma H, Kohyama K, Park IK, et al. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Brain 2004; 127: 2201-2213.
16. Soares RM, Dias AT, De Castro SB, et al. Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process. Autoimmunity 2013; 46: 480-485.
17. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.
18. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71: 93-100.
19. Li Y, Xie P, Lv F, et al. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 2008; 118: 218-225.
20. Khanna S, Sharma A, Huecker J, et al. Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J Neuroophthalmol 2012; 32: 216-220.
21. Storoni M, Davagnanam I, Radon M, et al. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: A novel magnetic resonance imaging scoring system. J Neuroophthalmol 2013; 33: 123-127.
22. Graves J, Kraus V, Soares BP, et al. Longitudinally extensive optic neuritis in pediatric patients. J Child Neurol 2015; 30: 120-123.
23. Akaishi T, Sato DK, Nakashima I, et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: A comparative study. J Neurol Neurosurg Psychiatry 2015; doi: 10.1136/jnnp-2014-310206. [Epub ahead of print]
24. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
25. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
26. Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: Predictors of response. Neurology 2002; 58: 143-146.
27. Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 2012; 135: 1834-1849.
28. Kleiter I, Hellwig K, Berthele A, et al. Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 2012; 69: 239-245.
29. Min JH, Kim BJ, Lee KH,. Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler 2012; 18: 113-115.
30. Trebst C, Jarius S, Berthele A, et al. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014; 261: 1-16.
31. Saadoun S, Waters P, Owens GP, et al. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun 2014; 2: 35.